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Conformational flexibility of molecules involved in crystal growth and dissolution is rarely investigated in
detail, and usually considered to be negligible in the formulation of mesoscopic models of crystal growth. In
this work we set out to investigate the conformational isomerism of ibuprofen as it approaches and is incorpo-
rated in the morphologically dominant {100} crystal face, in a range of different solvents - water, 1-butanol,
toluene, cyclohexanone, cyclohexane, acetonitrile and trichloromethane. To this end we combine extensive
molecular dynamics and well-tempered metadynamics simulations to estimate the equilibrium distribution of
conformers, compute conformer-conformer transition rates, and extract the characteristic relaxation time of
the conformer population in solution, adsorbed at the solid/liquid interface, incorporated in the crystal in
contact with the mother solution, and in the crystal bulk. We find that, while the conformational equilibrium
distribution is weakly dependent on the solvent, relaxation times are instead significantly affected by it. Fur-
thermore, differences in the relaxation dynamics are enhanced on the crystal surface, where conformational
transitions become slower and specific patways are hindered. This leads to observe that the dominant mecha-
nisms of conformational transition can also change significantly moving from the bulk solution to the crystal
interface, even for a small molecule with limited conformational flexibility such as ibuprofen. Our findings sug-
gests that understanding conformational flexibility is key to provide an accurate description of the solid/liquid
interface during crystal dissolution and growth, and therefore its relevance should be systematically assessed
in the formulation of mesoscopic growth models.
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I. INTRODUCTION
Cystallisation is a key step in the production of ac-
tive pharmaceutical ingredients (APIs) as it can deter-
mine their purity, bulk structure, and size and shape
distributions. Crystal habits of APIs are known to af-
fect their mechanical properties and bulk density1,2, as
well as their dissolution rates and consequently, their
bioperformance3,4. The shape of crystal particles also im-
pacts their compaction properties5 and handling in pow-
der form with flakes and needles being the most difficult
to process6. A number of factors affect crystal growth
from solution such as, the identity of the solvent, pres-
ence of impurities and cooling rate. The modification of
the crystal habit of organic molecules by changing the
solvent has been extensively studied7–9, stressing the im-
portance of crystal habit prediction for optimal process
and product design10.
The shape of a crystal grown from solution is deter-
mined by the relative growth rate of individual crystal
faces exposed to the solvent. Crystal faces of great mor-
phological importance grow slowly compared to other
faces, whilst faces characterised by a small surface area
are fast-growing. Being able to predict crystal shapes
a)Electronic mail: m.salvalaglio@ucl.ac.uk
depends on obtaining reliable information on the growth
kinetics of individual faces, either through molecular
simulations or energy approximations in mathematical
models11. Over the last few decades, significant progress
has been made in the accurate prediction of solution
grown crystal shapes and a number methods have been
developed, some of which have the capability of account-
ing for solvent effects. The current state of the art in
this field comprises of approaches relying on mechanistic
models or molecular simulations. In particular, the most
recent contribution in the area of mechanistic models is
represented by the work of J. Li and M. Doherty12. In
their work, the authors introduce a mechanistic spiral
growth (MSG) model to predict the steady state mor-
phologies of a paracetamol crystal, grown from 30 dif-
ferent solvents. The method comprises of kink rate and
kink density calculations, as well as solvent interaction
calculations. The predicted morphologies match the ex-
perimental shapes very well for the cases of vapour and
water growth, demonstrating the accuracy of the theory.
In turn, molecular dynamics (MD) simulations, are in-
valuable for exploring the dynamic evolution of systems
of interest, though at times the domain of applicability
of MD can be limited by sampling.
In current crystal shape prediction methods, confor-
mational flexibility is typically neglected. In fact, a gen-
eral approach to the systematic incorporation of con-
formational flexibility in crystal growth models is still
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2missing13. In this work we aim to highlight how, even
for relatively small molecules, conformational flexibility
and crystal growth/dissolution are inherently coupled.
To tackle this problem we analyse the conformational
flexibility of a single ibuprofen molecule in four states
along its path of incorporation into the crystal bulk. We
choose to focus on a single molecule as a conformation-
ally flexible unit rather than making an assumption on
the nature of the growth unit involved in the process.
The four states are depicted in FIG. 1) and include:
bulk solution, surface adsorbed, within the outer crystal
surface layer and in the bulk of the solid. For all states
we investigate how the solvent, as well as the structure of
a crystal/solution interface impacts ibuprofen conforma-
tional transition kinetics, thermodynamics and mecha-
nisms. Our work paves the way towards a formulation of
solvent-dependent kinetic models for the growth and dis-
solution of flexible molecules, necessary to predict crystal
shape evolution in systems of practical relevance.
FIG. 1. Scheme of states of an ibuprofen molecule along
the process of incorporation in the crystal bulk - in the bulk
solution (yellow frame), surface adsorbed, on an ordered or
disordered surface (red frame), within the outer crystal sur-
face layer of an ordered or disordered surface (purple frame),
in the bulk of the solid (black frame).
II. METHODS
In the present study we investigate the conformational
flexibility of ibuprofen in four different states as described
in FIG. 1 using all-atom MD simulations. Since re-
sults from MD are only meaningful when all energetically
relevant configurations have been explored, in certain
cases, MD is combined with well-tempered metadynam-
ics (WTmetaD)14 for computational efficiency. State-to-
state kinetics and conformational rearrangement mech-
anisms are then reconstructed within the theoretical
framework of Markov State Models (MSM)15.
A. Simulation setup
MD simulations were performed with Gromacs 5.1.416
using the Generalised Amber Force Field (GAFF)17 and
an explicit representation of the solvent. Force field pa-
rameters for solvent molecules were obtained from the
Virtual Chemistry solvent database18,19. Where relevant,
WTmetaD and collective variable post-processing have
been carried out using Plumed 2.320 .
Seven solvents were considered in this study - water,
1-butanol, toluene, cyclohexanone, cyclohexane, acetoni-
trile and trichloromethane. The conformational complex-
ity of the ibuprofen molecule was considered for each sol-
vent in a surface state, an adsorbed state and in solu-
tion. In our study we have considered the morpholog-
ically dominant {100} crystal face. Due to the layered
character of the {100} face and depending on where a
slice is made, either polar or apolar functionalities may be
exposed to the external environment, as shown in FIG. 2.
In the present study, we investigate both scenarios for
each solvent, as discussed in detail in the results section.
FIG. 2. a) Ibuprofen {100} polar surface (left) and b) ibupro-
fen {100} apolar surface (right), where solvent molecules are
represented as spheres for simplicity.
The kinetic and thermodynamic information in each
case was recovered using independent simulations. In ad-
dition, kinetics recovered with the aid of metadynamics
involved performing 50 simulations per starting configu-
ration. For a detailed summary of all simulations per-
formed please refer to Section A of the Supplementary
Material.
Molecular Dynamics Setup Prior to MD each sys-
tem undergoes an energy minimisation using a conju-
gate gradient algorithm with a tolerance on the maxi-
mum residual force of 100 kJ mol−1 nm−1. In all MD
simulations a cut-off of 1.0 nm for non-bonded interac-
tions is chosen, three-dimensional periodic boundary con-
ditions (pbc) are applied and long range intermolecular
interactions are included using the particle-mesh Ewald
(PME) approach21. A time step of 2 fs was used in
conjunction with constraining the fast bond vibrations
by applying the LINCS algorithm22. All of the simu-
lations analysed in this work were carried out within
the isothermal-isobaric (NPT) ensemble at pressure of
1 bar and temperature of 300 K, using Bussi-Donadio-
Parrinello thermostat23 and Berendsen barostat24. Cou-
3pling between the x, y and z components in the barostat
setup is varied based on the environment in which the
conformational flexibility of ibuprofen is investigated. A
fully isotropic pressure control is used for bulk solution
simulations. For simulations in the crystal bulk, we apply
an anisotropic pressure scaling, in order to explicitly ac-
count for any potential deformation of the crystal lattice
induced by local conformational transitions. Simulations
of the solid/liquid interface are carried out by using a
semi-isotropic pressure control, as it allows the contin-
uous adaptation of the system volume by scaling only
the z-coordinate, avoiding rescaling distances on the x,y
plane, which could destabilise the crystal slab.
Collective Variables The conformational ensemble of
ibuprofen is mapped on a two-dimensional collective vari-
able (CV) space, defined by two internal torsional angles
that represent a global and local rearrangement of the
ibuprofen molecular structure. As shown in Fig. 3, the
global torsion captures the relative orientations of the
para-substituents with respect to one another around the
plane of the phenyl ring, whereas the local torsion cap-
tures the relative rotational angle of the methyl groups
of the isobutanyl substituent.
FIG. 3. Internal torsional angles of ibuprofen used to map
the conformational space of the molecule. a) Global torsional
angle monitors the rotation of the methyl groups around the
vertical axis of the molecule and b) Local torsional angle mon-
itors the degree of interchange between the methyl groups.
For a quantitative assessment of the crystal-solution
interface structural rearrangement we define an order pa-
rameter (SMAC) that captures the local order within the
coordination sphere of an ibuprofen molecule. SMAC is
based on the evaluation of the density of the first coordi-
nation shell and on the relative orientation of neighbours,
considering the bulk crystal structure as a reference. De-
tails for the mathematical definition of SMAC can be
found in Ref.25 and26. The SMAC parameters used for
ibuprofen in the present study are reported in Section B
in the Supplementary Material.
WTmetaD Setup WTmetaD has been used as a tool
to increase the sampling efficiency of ibuprofen conforma-
tional space14, as shown for a representative simulation
trajectory in Fig. 4b). This allows us to compute free
energy surfaces (FES) in CV space, and to estimate the
rate of rare conformational transitions27. In WTmetaD
simulations an external time-dependent biasing potential
is introduced as a function of the torsional angle CVs dis-
cussed earlier. The external bias potential is defined as
a sum of Gaussian functions. The height and width of
the Gaussian functions, the pace of bias update and the
bias factor are the parameters controlling the construc-
tion of the bias potential28. In Tab. I we report the
parameters used for simulations to construct the free en-
ergy surface of the conformational space of ibuprofen, as
well as for simulations used to calculate rates of confor-
mational transitions.
TABLE I. Parameters in WTmetaD simulations, used to com-
pute free energy surfaces (FES) and conformational transition
rates.
Width Height Bias Factor Pace
[ rad ] [kBT ] [K] [steps]
FES 0.1 0.96 10 500
Rates 0.1 0.24 5 1500
Conformational equilibrium probability distribution
from WTmetaD The FES computed in collective vari-
ables space F (S) provides information on the equilibrium
probability density p(S), defined as:
p(S) =
e−βF (S)∫
Ω
e−βF (S)dS
(1)
where Ω indicates the entire configuration space, and
β−1 = kBT , where kB is the Boltzmann constant. The
FES projected in the space of the global and local tor-
sional CVs can therefore be used to compute the equi-
librium probability of different conformers. For instance,
as shown in the Fig. 4a), a typical FES displays a set of
local minima. Each minimum corresponds to the projec-
tion in CV space of an ensemble of configurations that
can be identified as a single ibuprofen conformer. Hence,
by integrating the probability density p(S) over the sub-
domain corresponding to a local minimum in CV space,
one can obtain the equilibrium probability of the con-
former corresponding to that minimum. For the generic
conformer i, the equilibrium probability Pi is computed
as:
Pi =
∫
Ωi
p(S)dSn (2)
where Ωi indicates the region of CV space pertaining to
conformer i. The integration domains of each conformer
have been indicated in Fig. 4a) in red. The free en-
ergy difference between any pair of i and j conformers is
therefore computed as ∆Fi,j = −β−1 log PjPi . The conver-
gence of WTmetaD simulations has been systematically
assessed by monitoring free energy differences between
conformers as a function of simulation time, as shown in
Fig. 4c). Each simulation is considered converged once
the fluctuations in the free energy between the minimum
4FIG. 4. a) Free energy surface in the conformational space of the two internal torsional angles of ibuprofen showing the
integration domain used for calculating equilibrium distributions from WTmetaD in red and the core set domain in yellow.
Molecular structures of the conformers identified by the local minima are reported alongside the FES. b) Global (orange) and
Local (purple) torsional angle vs. time in a WTmetaD simulation c) Convergence of free energy differences of conformers with
respect to c1. d) State to state transitions in an unbiased MD simulation. e) Conformer lifetime distribution for an ibuprofen
molecule in the apolar {100} surface in water, recovered with the aid of WTmetaD.
corresponding to conformer c1 and all other conform-
ers are less than 5 kJ mol−1. In the cases in which the
sampling of the conformational space has been restricted
through the application of a static bias potential, an ap-
propriate reweighting of the results has been carried out.
Kinetics from WTmetaD Performing metadynamics
with the aim of obtaining conformational transition ki-
netics requires constructing bias to favour the escape
from a local free energy minimum without perturbing
the transition state ensemble. This is typically achieved
by reducing the pace of bias construction27, and by com-
5paring the shape of the transition times distribution with
that of an exponential distribution implied by the law of
rare events29, as shown in FIG. 4e). In this work we
carry out this process by constructing distributions of
transition times from 50 events obtained from indepen-
dent WTmetaD simulations. Results of the Kolmogorov-
Smirnov test, employed to analyse the shape of the dis-
tribution of transition times, are reported in Tab. IV in
the Supplementary Material.
B. Construction of a Markov State Model
a. Equilibrium probability and system relaxation time
In this work, we are interested in using a Markov State
Model (MSM) to compute the global relaxation rate of
the conformational population, the mechanism of conver-
sion between conformers, and their equilibrium popula-
tions. The equilibrium populations obtained from meta-
dynamics have been used to cross-validate the MSM (see
the Supplementary Material, Section F). An MSM is de-
fined by a master equation of the following form:
P˙(t) = KP(t) (3)
where P(t) is the vector with the probabilities of each
macrostate at time t, and K is a transition rate matrix
which has off-diagonal elements kij ≥ 0 and diagonal
elements kii = −
∑
j 6=i kji < 0
15,30.
Elements of the transition rate matrix can be com-
puted either from unbiased simulations or from meta-
dynamics, depending on the inherent timescale of the
process31. In the case of unbiased simulations we apply
a lifetime-based estimate32 of the transition rate from
state i to state j: kij = τi
−1nij , in which τi is the total
residence time in state i and nij is the total number of
transitions from state i to state j. Transitions were ac-
counted for only when the so-called core set of state j is
reached. By doing so, we avoid including non-Markovian
transitions in our analysis32. Core sets for all the ibupro-
fen conformational isomers are shown in FIG. 4a) in yel-
low. A representation of state-to-state transitions within
a typical trajectory is shown in FIG. 4d). For the cases
where it is more practical to obtain kinetic information
from metadynamics for computational efficiency, individ-
ual simulations starting from each conformer where car-
ried out. The distribution of transition times was then
compared to an exponential distribution, assessing their
compatibility with a Kolmogorov-Smirnov test at 95 %
significance FIG. 4e).
Eq. 3, admits a unique stationary equilibrium distri-
bution, determined by15,30,32:
KPeq = 0 (4)
Solving for the eigenvalues and eigenvectors of the transi-
tion rate matrix K allows us to extract equilibrium prob-
abilities of the conformational isomers Peq and relaxation
times. The eigenvalues of the matrix K can be sorted by
magnitude: λ1 = 0 > λ2 ≥ λ3 ≥ ... ≥ λN . The equi-
librium population is obtained from the normalization of
the left eigenvector corresponding to λ1 = 0. The largest
non-zero eigenvalue of the K matrix corresponds to the
relaxation time of the slowest mode of the system.
b. Transition pathway between macrostates An
MSM is a powerful tool for studying the most likely
transition pathway between any two macrostates of the
system. To this end, a knowledge of the transition prob-
ability matrix T between all miscrostates is required.
Elements of the transition probability matrix Tij can
be estimated from MD simulation by computing the
number of transitions between each pair of states i and
j, Cij:
Tij =
Cij∑N
k=1 Cik
(5)
where k represents each of the N macrostates.
With the knowledge of the transition probability ma-
trix, a discrete transition pathway between any two states
A and B is obtained by computing the committor prob-
ability qn
+. The latter is the probability that, when in
the generic state n, which belongs to the ensemble of
all intermediate states I, the system will visit state B be-
fore state A. The committor probability qn
+ is computed
as15:
− q+n +
∑
kI
Tnkq
+
k = −
∑
TnB for nI (6)
where k runs over the ensemble of all intermediate
macrostates of the system. By definition, the commit-
tor probability in the starting state A is 0 and in the
final state B is 1.
Once the committor probability for all states along
the the discrete transition pathway between A and B is
obtained, the net state-to-state probability flux between
any two states i and j, f+ij , is calculated using Eq. 7
15:
f+ij = piiTij(q
+
j − q+i ) (7)
The net flux and the committor probability allow us to
quantitatively identify transition pathways and to infer
model-based mechanistic hypotheses, reported in the Dis-
cussion section of the paper.
III. RESULTS
In this section we report thermodynamic and kinetic
results as well as the mechanism for the conformational
transitions of ibuprofen in solution and at the morpho-
logically dominant {100} face. In determining the crys-
tal face with largest morphological importance we rely
on BFDH model calculations, obtained using the soft-
ware Mercury33, as well as experimental studies of sol-
vent effects on the shape of ibuprofen crystals9,34. An
6FIG. 5. a) Equilibrium distribution of ibuprofen conformers in solution of different solvents recovered from WTmetaD. The
solvents are shown in the order: water, 1-butanol, toluene, cyclohexanone, cyclohexane, acetonitrile, trichloromethane. Equi-
librium distributions of ibuprofen conformers recovered from DFT/COSMO calculations and from MSMs are reported in the
Supplementary Material (Fig. 3, Fig. 6, Fig. 7 and Fig. 8). b) System equilibration times for an ibuprofen in solution obtained
from MSM analysis.
extensive number of simulations (Supplementary Mate-
rial, Section A) were performed in seven different solvents
varying in size, polarity, and hydrogen bonding capa-
bilities. The solvents considered are water, 1-butanol,
toluene, cyclohexanone, cyclohexane, acetonitrile and
trichloromethane.
To assess the effect of the presence of a crystal/solution
interface we investigate ibuprofen conformational transi-
tions in the four states mentioned in the introduction
and sketched in FIG. 1. We start by introducing the
results obtained for the equilibrium distribution and re-
laxation kinetics of ibuprofen conformers in bulk solu-
tion, as shown in FIG. 1a). In this case a single ibupro-
fen molecule is surrounded by solvent molecules in the
absence of a crystal surface. Next, we discuss the equi-
librium population of ibuprofen conformers found in the
crystal bulk as shown in FIG. 1d). We complete the
results on the dynamics and thermodynamics of confor-
mational transitions with reporting the states at the crys-
tal/solution interface, such as those sketched in Fig. 1b,
c). We conclude with a discussion on the mechanisms of
conformational transitions obtained from the MSMs.
A. Ibuprofen in bulk solution
Equilibrium distribution of conformers in solution
To assess the impact of solvent on the equilibrium
probability of ibuprofen conformers in solution we car-
ried out WTmetaD simulations of an isolated ibupro-
fen molecule, as described in the methods section. Such
simulations uncovered six stable conformers present in
each of the seven solvents investigated. The free energy
surface for the case of an ibuprofen molecule in water
is shown in FIG. 4a) with the conformers labelled c1
through to c6. A comprehensive summary of all the free
energy surfaces computed, accompanied by an analysis
of their convergence, is reported in Fig. 9 and Fig. 10 of
the Supplementary Material.
The equilibrium probability of conformers in solution,
7computed using Eq. 1 and 2, shows that conformers c1,
c2, c4 and c5 dominate the distribution. Each of these
conformational isomers contribute to approximately one
fifth of the overall distribution. The remaining two con-
formers, c3 and c6, are significantly less probable, each
accounting for 5% of the total conformer population. The
lower probability of the latter two conformers can be ac-
counted for by considering the position of the methyl
groups of the iso-butanyl substituent with respect to the
phenyl ring. Whilst in conformers c1, c2, c4 and c5 one
of the methyl substituents is always pointing away from
the molecule, in line with the central axis which con-
tains the phenyl ring, in the case of conformers c3 and
c6, the two groups are both equally close to the phenyl
ring. This observation suggests that conformers c3 and
c6 are much less probable due to the created steric effect.
Small, but significant variations between the equilibrium
probabilities of each conformer outside the calculated er-
ror are observed, indicating a weak dependence of the
conformational distribution on the solvent. The equi-
librium distribution of conformers identified from meta-
dynamics was independently confirmed though a genetic
search for stable structures35, coupled with free energy
calculations, performed with internal gas-phase free en-
ergies calculated using Gaussian 0936 in conjunction with
the PBE0/6-31G(d) functional, along with solvation free
energies derived from COSMO37 calculations. The num-
ber of stable ibuprofen conformers and their equilibrium
probability found with the DFT/COSMO procedure are
in qualitative agreement with the results obtained with
WTmetaD, indicating that the collective variables cho-
sen allow to exhaustively explore the internal degrees of
freedom of the molecule and that the forcefield chosen
for this study does not introduce significant artefacts.
Relaxation Dynamics of the conformer population
Unbiased MD simulations of an isolated ibuprofen
molecule in different solvents allowed us to compute
state-to-state transition probabilities and construct a
Markov State Model. Stable conformational states were
defined according to the position of the local free energy
minima identified in CV space. Core sets were consid-
ered to identify state-to-state transitions as reported in
Fig. 4a). The equilibrium probability obtained from the
MSM is in good agreement with the result obtained from
WTmetaD (Supplementary Material, Fig. 6), providing
a consistency check for our sampling strategy. Relaxation
times were derived for each solvent from the MSM model
and are reported in FIG. 5b). Relaxation times show
that, while the equilibrium distribution of conformers
varies only slightly between solvents, the system equili-
bration dynamics differs more substantially. The slowest
equilibration in solution is computed in water, where the
system equilibrates in just under 1 ns. The second longest
time is registered for 1-butanol. In the remaining solvents
relaxation times are all of the order of half a nanosecond.
These results indicate that hydrogen bonding with the
solvent are able to affect the interconversion dynamics
of ibuprofen conformational isomers in solution, even if
their contribution to the equilibrium distribution of con-
formers is limited.
B. Equilibrium distribution and lifetime of ibuprofen
conformers in the crystal bulk
WTmetaD was also employed to sample the confor-
mational space accessible to an ibuprofen molecule in
the bulk of the crystal. The free energy surface com-
puted for this case is reported in Fig. 6b). An analysis
of the associated conformer equilibrium distribution re-
vealed that, while conformer c1 has a 98 % probability,
ibuprofen maintains a non-negligible conformational flex-
ibility in the crystal bulk. Conformers involving a rota-
tion along the local torsional angle can be observed and
account for 2% of the equilibrium distribution. With the
aid of infrequent metadynamics, the lifetime of conformer
c1 was estimated to be of the order of 100 ns. The p-value
associated with the Kolmogorov-Smirnov statistic of the
escape time distribution29 is reported in Tab. VII in the
Supplementary Material. In all of the trajectories used to
compute the escape time from the local minimum corre-
sponding to conformer c1, the escape leads to conformer
c2.
C. Equilibrium distribution and lifetime of ibuprofen
conformers at the crystal-solution interface
In this section we report the results obtained for
an ibuprofen molecule, adsorbed on the crystal surface
(state b in Fig. 1), or embedded in the surface layer
in contact with the liquid solution (state c in Fig. 1).
We find that the conformational population and the sys-
tem equilibration times in the states at the crystal solu-
tion/interface depend on the structure of the surface, as
well as on the polarity of the functional groups in con-
tact with the solution (see FIG. 2 for polar and apolar
layer descriptions). To quantify the effect of the solvent
on the surface roughness and stability we use the order
parameter SMAC. A detailed overview of the effect of
each solvent on the behaviour of the both apolar and
polar {100} crystal faces can be found in Section C of
the Supplementary Material. In Tab. II we summarise
the effect of surface-solvent interactions on the surface
roughness and stability of the adsorbed state.
Free energy surfaces for an ibuprofen adsorbed on the
crystal surface and embedded in the outer layer of the
crystal configurations for the water/ibuprofen interface
are reported in Fig. 6 a), c) and d). Equilibrium prob-
ability of the c1 - c6 conformers moving from the bulk
of the liquid (water) to the bulk of the crystal are re-
ported in Fig. 6e). Characteristic relaxation times of the
conformer population for surface/adsorbed and solution
8TABLE II. Interface structure and stability of the adsorbed
state for all interface-solvent combinations.
solvent interface
polar apolar
structure ads. state structure ads. state
water ordered no ordered yes
1-butanol disordered yes ordered yes
toluene unstable - ordered no
cyclohexanone ordered yes ordered yes
cyclohexane unstable - ordered yes
acetonitrile disordered yes ordered no
trichloromethane unstable - ordered no
states for the apolar and polar surface layers are reported
in Fig. 7a) and in Fig. 7b) respectively .
Ibuprofen adsorbed on the crystal surface
The equilibrium distribution of ibuprofen conformers
adsorbed on the {100} crystal surface resembles closely
the distribution obtained in solution. Slightly higher
probability of c2, c4 and c5 is observed in certain solvents
(see section F of the Supplementary Material), reveal-
ing signs of conformationally-selective adsorption. MSMs
were built using unbiased MD simulations for the stable
adsorbed states. The model was again verified by com-
paring the equilibrium distribution from MSM to the one
recovered from WTmetaD (see Fig. 7 in Supplementary
Material). The interplay between solvent and interface,
however, has in this case a much more remarkable effect
on the system dynamics. Relaxation times in the ad-
sorbed state on an apolar surface show a different trend
with respect to those computed in solution. For instance,
in the adsorbed state equilibration is the slowest in 1-
butanol, 1.4 ns, followed by cyclohexanone of around 1
ns. Contrary to what is observed in the solution bulk,
conformational relaxation in the adsorbed state is the
fastest for the crystal/water interface. Equilibration time
on the polar surface for the case of 1-butanol is the same
as in the adsorbed configuration on the apolar surface.
In the case of cyclohexanone, however, equilibration on
the polar surface is significantly slower, 5 ns, than its
counterpart on the apolar surface. This five-fold increase
in the relaxation time shows that the character of the
surface impacts dynamics more significantly than ther-
modynamics, i.e. differences in the equilibrium proba-
bility of conformers in the two surfaces in fact do not
exceed 10%. A complete summary of conformational re-
laxation times for the adsorbed state can be found in
Tab. III. These results clearly indicate that the kinetics
of conformational rearrangement of adsorbed molecules
are dictated by specific solvent-surface interactions, and
their relaxation timescale differs from that computed in
solution.
TABLE III. Relaxation times [ns] for the adsorbed states on
polar and apolar {100} ibuprofen surface. Only cases in which
the adsorbed state is stable have been reported.
solvent Relaxation times [ns]
polar apolar
water - 0.6
1-butanol 1.5 1.4
toluene - -
cyclohexanone 5.0 0.9
cyclohexane - 0.8
acetonitrile - 2.1
trichloromethane - -
Ibuprofen embedded in the crystal surface
The equilibrium distribution within the surface layer of
the {100} crystal is dominated by the c1 conformer with
an equilibrium probability higher than 80%, for both the
apolar and polar faces. The probability distribution sug-
gests that rotations along the local torsional angle are as-
sociated to a lower energy penalty regardless of whether
the CH3 groups are in direct contact with the solvent.
Particularly low probability for c1 is found for the case
of 1-butanol in the polar surface. This is due to sur-
face roughening, which allows for a higher conformational
flexibility. (Fig. 5 in Section F of the Supplementary
Material) In the case of the polar surface in acetonitrile
we find that perturbing the conformational space of a
surface molecule, by adding biasing potential within the
framework of WTmetaD, causes its detachment, indicat-
ing that detachment from the surface is coupled with its
conformational transition. Overall, highlighting equilib-
rium distribution variations between states involved in
dissolution shows that embedding an ibuprofen molecule
in the surface layer provides a significant conformational
selectivity. In fact, c1→ c4 and c1→ c5 become so rare,
that the probability of c4 and c5 reduces to less than 1 %.
We build MSMs for all surface/solvent couples, based on
the kinetics of state-to-state transitions, obtained from
WTmetaD simulations. The equilibrium distribution ob-
tained is once again in good agreement with the one from
WTmetaD (Fig. 8 in the Supplementary Material), con-
firming the internal consistency of the results obtained.
With the exception of water, relaxation times computed
from MSMs show that conformational equilibration in
the apolar surface increase substantially for all solvents
compared to the solution case. Relaxation times range
between 1 and 2 ns (2-5 times slower than in solution,
see Fig. 7a), with the largest slowdown registered for
the case of 1-butanol. Conformational equilibration of
ibuprofen in the polar {100} surface on the other hand,
is characterised by the same relaxation time as in solu-
tion (see Fig. 7b), around 1 ns. Water represents once
again an exception. We observe that its relaxation time
in the polar surface is counter-intuitively faster than in
the bulk solution (0.2 vs 1 ns).
9FIG. 6. a-d) Free energy surfaces of an ibuprofen molecule in water, adsorbed on the solid/liquid interface (a), in the crystal
bulk (b), embedded in the apolar crystal surface (c) and in the polar crystal surface (d). It can be noted that the accessible
conformational space is systematically reduced as the molecule moves from solution to the crystal bulk and that the topology of
the surface changes moving from the adsorbed to the surface state. e) Equilibrium probability of the six ibuprofen conformers
c1 - c6, found in the stages involving incorporation of a molecule into the crystal, considering water as a solvent and an apolar
{100} crystal surface.
D. Discussion
Conformational equilibrium distribution In this study
the conformational flexibility of ibuprofen is investigated
with the aid of MD simulations in combination with
WTmetaD and the theoretical framework of the Markov
State Model. In all cases we find good agreement be-
tween the equilibrium distribution obtained from WT-
metaD and the MSM constructed from individual tran-
sition rates. Based on these findings, we can conclude
that the free energy landscape of ibuprofen conformers
is strongly dependent on the environment (solution, ad-
sorbed, interface, crystal bulk) and weakly dependent on
the solvent. The latter is further confirmed by the equi-
librium distribution obtained with DFT/COSMO calcu-
lations, which also predict minimal variability in the equi-
librium distribution of conformers in different solvents.
Conformational selectivity is observed in the adsorbed
state and the surface state of the ibuprofen molecule, and
is particularly obvious in the crystal bulk. Despite the
fact that the polar and apolar {100} surfaces expose dif-
ferent functional groups of the molecule to the solution,
we find that the conformational distribution of ibupro-
fen in both is very similar, indicating that rotation along
the local torsional angle is more energetically favourable
than along the global one in both cases.
Relaxation dynamics of the conformer population We
use MSMs to obtain the characteristic equilibration time
for the population of conformers c1 - c6 in all of the
states investigated. In most cases the presence of a sur-
face only marginally slows down the global conforma-
tional rearrangement. Nonetheless, it can be concluded
that the system relaxation times are both environment
and solvent dependent. More importantly, there is a sig-
nificant difference in the computed trends between the
polar and apolar {100} surfaces. Whilst in the apolar
{100} surface case the system equilibration generally in-
creases when moving from solution to the surface, in the
case of the polar surface the relaxation times increase in
the adsorbed state and decrease again in the surface. The
solid/liquid interface of the polar and apolar interfaces
has significantly different roughness. We can conclude
that conformational rearrangement of ibuprofen in both
the surface and in the adsorbed state depends strongly
on specific solvent-surface interactions.
Equilibration mechanism While the global relaxation
time of the conformational population slows down only
marginally, there is a clear modification in the mechanism
of conformational rearrangement of ibuprofen molecules
when moving from considering the bulk solution to the
crystal surface. To quantify this change in terms of kinet-
ics, we investigate the escape rates from the bulk crystal
conformer c1 to each of its neighbours in CV space, c1→
c2, c1 → c3 and c1 → c4, in all stages of incorporation
with respect to the apolar {100} crystal slab. Transition
rates that have been obtained with the aid of metady-
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FIG. 7. System relaxation times, obtained through an MSM
analysis in the case of a) an apolar {100} surface and b) polar
{100} surface.
namics and/or the analysis of unbiased MD trajectories
are reported with circles in FIG. 8e). The rest of the
transition rates have been calculated using the ratio of
free energy barriers between states from WTMetaD cal-
culations (indicated with squares). We find that the con-
version c1→ c4 goes from being comparable to the c1→
c2 conversion in solution to being the slowest transition
in the crystal surface and in bulk. This indicates that the
rearrangement mechanism of conformers depends heavily
on the position with respect to the crystal interface.
In order to further investigate modifications in the con-
formational transition mechanism, we use the MSMs to
analyse a transition pathway from conformer c1 to con-
former c5. We find that in solution and in the adsorbed
state the most likely mechanism of conversion unfolds
via conformers c2 and c4, as indicated by the net flux in
FIG. 8a) and b). Looking at the mechanism of conver-
sion in the surface however, we find that it is dependant
on the surface-solvent interactions. For the case of an
ibuprofen in the apolar surface c1 to c5 transition occurs
exclusively via conformer c3 FIG. 8c), whilst for the case
of a polar surface the most likely mechanism is a direct
transition FIG. 8d).
IV. CONCLUSIONS
By combining extensive unbiased MD, WTMetaD and
MSMs, in this study we propose a systematic approach at
the identification of kinetics, thermodynamics and tran-
sition mechanisms of relevant conformational transitions
of organic molecules at the crystal/solution interface.
Here we investigate conformational isomerism of
ibuprofen at the solid-liquid interface. We find that the
equilibrium distribution of conformers is strongly depen-
dent on the environment of the molecule with respect
to the crystal surface. When in contact with the {100}
surface, the conformational rearrangement time generally
increases moving from the solution to the surface states,
and differs between solvents. On the other hand, the
conformational rearrangement in the polar {100} surface
exhibits different kinetic behaviour and relaxation times
in the surface are very similar to those in solution. We
find that the specific solvent/surface interactions govern
the conformational behaviour of the molecule. Moreover,
in both the polar and apolar surfaces we find a change in
the mechanism of conformational rearrangement with re-
spect to bulk solution. With these results we show that,
even in a moderately flexible molecule such as ibuprofen,
thermodynamics, kinetics and mechanisms of conforma-
tional equilibria are significantly affected by the presence
of a crystal interface and by its interplay with the sol-
vent. This finding highlights the need to develop system-
atic approaches for including conformational transitions
in mesoscopic models of crystal growth.
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SUPPLEMENTARY MATERIAL
See supplementary material for a list of simulations,
the set up of the collective variables used to charac-
terise the surface structures, a detailed description of the
surface-solution interactions observed, free energy sur-
faces for all the states in all solvents considered, conver-
gence of free energy differences, and conformer popula-
11
FIG. 8. a) Mechanism of conversion of conformer c1 to conformer c5, in solution (a), an adsorbed configuration on the apolar
{100} crystal surface (b), embedded in the apolar {100} crystal surface (c) and in the polar {100} crystal surface (d). In all four
cases the solvent is water. The colour of the states represents the probability of converting to conformer c5. The net probability
flux is represented through line thickness. b) Conversion rates between c1 and neighbouring conformers in CV space going
through the four states considered in this study. Data points marked with circles have been obtained through unbiased MD
or recovered from well-tempered metadynamics, while the data points in squares have been computed using known transition
rates and free energy barriers between relevant states.
tions in all states computed with WTmetaD and MSM,
and conformers probability in solution computed with
the DFT/COSMO procedure.
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SUPPLEMENTARY MATERIAL
A. Simulations performed
Tab. I provides a summary of all simulations per-
formed towards the characterisation of the thermody-
namics and the kinetics of the conformational transitions
of ibuprofen. In Tab. II the approximate computational
time [ns] taken for each type of simulation has been sum-
marised.
a. Bulk Solution In bulk solution, the information
on the equilibrium probability of ibuprofen conformers
was extracted from MD with WTmetaD simulations, one
for each of the solvents. Kinetic information was obtained
by analysing one unbiased MD trajectory per solvent and
recording the state-to-state transitions.
b. Adsorbed state In the adsorbed states, thermody-
namic information was, again, extracted with the aid of
WTmetaD, however, additional static bias was applied to
prevent detachment from the surface and increase com-
putational efficiency. Kinetic transitions between states
were extracted from unbiased MD simulations for those
solvents which stabilise an adsorbed state. Fifty MD sim-
ulations were performed for each solvent case to ensure
thorough sampling as static bias was not applied in this
case and simulations were stopped upon detachment of
the molecule from the surface. The duration of the simu-
lations was therefore the lifetime of the state in the range
of a few nanoseconds.
c. Surface state In the crystal surface, similarly to
the other cases, thermodynamic information was ob-
tained with the aid of WTmetaD for each solvent case.
Kinetic information was recovered from WTmetaD sim-
ulations for computational efficiency. To this aim, all
six conformers were categorised as starting configurations
and 50 simulations per starting configuration were per-
formed. The simulations were stopped upon observing
a conformational transition. This procedure was carried
out for all solvents where a stable surface state exists.
d. Crystal bulk Finally, a single MD with WTmetaD
simulation was carried out to obtain the conformational
equilibrium probability of ibuprofen in the crystal bulk.
In the crystal, kinetic information was obtained only for
conformer c1 as a starting configuration with the aid of
TABLE I. Summary of simulations carried out in the confor-
mational study of ibuprofen
state thermodynamics kinetics
bulk solution 1× water 1× water
1-butanol 1-butanol
toluene toluene
cyclohexanone cyclohexanone
cyclohexane cyclohexane
acetonitrile acetonitrile
trichloromethane trichloromethane
adsorbed 1× water 50× water
state on 1-butanol 1-butanol
an apolar toluene cyclohexanone
{100} surface cyclohexanone cyclohexane
cyclohexane
acetonitrile
trichloromethane
adsorbed 1× water 5× 1-butanol
state on 1-butanol cyclohexanone
a polar toluene acetonitrile
{100} surface cyclohexanone
cyclohexane
acetonitrile
trichloromethane
surface 1× water 6×50× water
state in 1-butanol 1-butanol
an apolar toluene toluene
{100} surface cyclohexanone cyclohexanone
cyclohexane cyclohexane
acetonitrile acetonitrile
trichloromethane trichloromethane
surface 1× water 6×50× water
state in 1-butanol 1-butanol
a polar toluene cyclohexanone
{100} surface cyclohexanone
cyclohexane
acetonitrile
trichloromethane
crystal bulk 1× no solvent 1×30× no solvent
WTmetaD. 30 simulations were carried out for the pur-
pose.
2FIG. S1. a) Figure shows the vector description of the ibuprofen molecule in the crystal bulk. b) The plot in green shows
the characteristic intermolecular torsional angles distribution between molecular vectors in the crystal bulk, obtained with the
INTERMOLECULARTORSIONS utility in Plumed 2.3. The plot in red shows the Gaussian function kernels set up in SMAC.
B. SMAC parameters
The collective variable SMAC, as implemented in
Plumed 2.3, was used to quantify the roughness of the
surface/solution interface. The implementation of the
variable involves representing molecules of interest in a
vector form, as shown in FIG. S1a). The intermolecular
torsional angles distribution, characteristic for the crystal
bulk arrangement, is then studied to set up the variable.
The intermolecular torsions between the vectors defined
for ibuprofen were analysed in the crystal bulk and their
characteristic fingerprint, shown in FIG. S1b) in green,
was found. The SMAC variable requires an input of this
characteristic angle distribution in the form of Gaussian
functions kernels, which are used as a reference in the
evaluation of the degree of order of a cluster of molecules.
The kernels used for the setup are shown in FIG. S1b) in
red. The plumed file input for the SMAC variable is also
provided below.
SMAC ...
SPECIES=molecules
SWITCH={RATIONAL R 0=0.7}
MEAN
KERNEL1={GAUSSIAN CENTER=-3.14
SIGMA=0.1}
KERNEL2={GAUSSIAN CENTER=-1.85
SIGMA=0.15}
KERNEL3={GAUSSIAN CENTER=0.0 SIGMA=0.1}
KERNEL4={GAUSSIAN CENTER=1.85
SIGMA=0.15}
KERNEL5={GAUSSIAN CENTER=3.14
SIGMA=0.1}
SWITCH COORD={RATIONAL R 0=3.0}
LABEL=smac
... SMAC
FIG. S2. Plot of number of ordered molecules at the solu-
tion/surface interfaceof the polar {100} ibuprofen face vs. dis-
tance of the surface layer from the pseudobulk of the crystal
slab. State of the surface is analysed after 1-3 ns from the
begining of the simulation to ensure that equilibrated config-
uration has been reached. The plot shows three characteristic
cases of the solvent effect on the structure of the surface. In
the case of toluene (green), full dissolution of the surface is
observed, hence the surface is categorised as unstable. For the
case of cyclohexanone (purple), the surface remains stable and
ordered. In the case of 1-butanol (orange) as a solvent, the
crystal surface is stable, but roughened.
C. Analysis of the interface structure
After addressing the thermodynamics and kinetics of
the conformational transitions of an ibuprofen molecule
in bulk solution, we report results for the {100} crystal
interface. As briefly mentioned in the Methods section
we note that, due to the layered nature of the ibuprofen
3crystal, the {100} face exposes either a polar or an apolar
surface to solution. The polar {100} face is characterised
by the exposure of carboxylic groups towards the solu-
tion. The apolar {100} crystal face, on the other hand,
exposes methyl groups. To analyse structural features of
the polar and apolar layers at the crystal/solution inter-
face we carry out unbiased MD simulations. The degree
of order of polar and apolar crystal interfaces is mon-
itored during the relaxation dynamics through the cal-
culation of the SMAC order parameter we referred to
in the methods, developed ad-hoc for ibuprofen (for the
details see Section B). The dissolution of molecules be-
longing to the surface layer was monitored by comput-
ing their distance from the bulk. In Figure FIG. S2 we
report the configurations sampled by three different sur-
face/solution models in the order parameter / distance
space. Three different limiting behaviours emerge: stable
and smooth interface (purple set), stable and disordered
interface (orange set), and unstable interface that spon-
taneously dissolves (green set).
The apolar {100} face is stable and ordered in all of
the solvents considered and does not show signs of rough-
ening within simulation times of a few hundred nanosec-
onds. On the other hand, the polar {100} face displays
a much more dynamic behaviour, strongly influenced by
the solvent: while certain solvents cause roughening of
the surface or its complete dissolution, others promote
the stabilization of an ordered interface. Furthermore, we
observe that an ibuprofen molecule adsorbed on the crys-
tal surface is not stable for all the interface (polar/apolar)
solvent combinations. In particular, in the case of an
apolar surface, the adsorbed state exists for the case of
water, 1-butanol, cyclohexanone and cyclohexane. The
polar {100} surface was found to dissolve in toluene, cy-
clohexane and trichloromethane. This suggests that low
polarity solvents favour an interaction between the car-
boxylic groups of neighboring ibuprofen molecules, pro-
moting the distortion and dissolution of the surface. An
adsorbed state in the case of the polar surface was found
to be stable only in 1-butanol, cyclohexanone and ace-
tonitrile. A summary of the interface structural analysis
is reported in Tab. III. In the analysis of the ibupro-
fen conformational space and transition dynamics at the
crystal/solution interface we exclude all unstable states
uncovered in the analysis of the interface structure.
D. System relaxation time
System relaxation time was obtained by setting up a
Markov State Model, where each ibuprofen conformer is
considered a microstate. Tab. IV summarises conforma-
tional equilibration times of an ibuprofen molecule for all
states considered.
E. Residence times of ibuprofen conformers
The average residence time of each ibuprofen con-
former in all relevant environments have been sum-
marised in Tab. V, Tab. VI and Tab. VII. The latter
includes the p-values for the KS tests used to validate
the kinetic information recovered from WTmetaD. The
lifetime of the conformers in each environment was used
to set up the Markov State kinetic Models for the corre-
sponding states.
FIG. S3. Equilibrium distribution of ibuprofen conformers in
bulk solution obtained with COSMO.
F. Equilibrium Probability
The equilibrium probability recovered from the WT-
metaD simulations in solution was verified against
COSMO calculations as shown in FIG. S3. The Markov
State Models, set up of each state, have been verified
by comparing the equilibrium distribution obtained with
the MSM with the corresponding WTmetaD one. The
agreement between the two methos is shown in FIG. S4.
The percent c1 conformer found in each case discussed
can be found in Fig S5. The equilibrium probability
for all conformers in all discussed cases, recovered from
WTmetaD and MSM, can be found in FIG. S6, FIG. S7
and FIG. S8. The probability of the conformers recov-
ered from WTmetaD, and the associated error, has been
calculated using the last 30 % of each simulation for con-
vergence reasons.
FIG. S9 and FIG. S10 provide the free energy surface
and convergence plots for all cases.
4TABLE II. Table of approximate computational time [ns] for each type of simulation performed
bulk adsorbed state surface state crystal
solution apolar polar apolar polar bulk
thermodynamics 150 100 300 300 150 45
kinetics 250 2-5 2-5 up to 2 up to 2 2-3
TABLE III. Interface structure and stability of the adsorbed state for all interface-solvent combinations.
solvent interface
polar apolar
structure ads. state structure ads. state
water ordered no ordered yes
1-butanol disordered yes ordered yes
toluene unstable - ordered no
cyclohexanone ordered yes ordered yes
cyclohexane unstable - ordered yes
acetonitrile disordered yes ordered no
trichloromethane unstable - ordered no
TABLE IV. Table of system relaxation time [ns], recovered for a MSM, for each molecule state considered in the study.
bulk adsorbed state surface state
solution apolar polar apolar polar
water 0.94 0.57 - 0.94 0.27
1-butanol 0.78 1.58 1.51 1.81 1.04
toluene 0.66 - - 1.07 -
cyclohexanone 0.68 1.08 5.03 1.23 0.86
cyclohexane 0.60 0.79 - 1.68 -
acetonitrile 0.56 - 2.11 1.57 -
trichloromethane 0.58 - - 1.41 -
TABLE V. Table of residence time [ps] of each conformer for the case of an ibuprofen molecule in bulk solvent.
bulk solution c1 c2 c3 c4 c5 c6
[ps] [ps] [ps] [ps] [ps] [ps]
water 102 107 675 112 110 485
1-butanol 140 129 671 136 143 512
toluene 101 122 390 114 104 420
cyclohexanone 162 164 467 156 154 481
cyclohexane 134 158 366 161 147 325
acetonitrile 94 105 305 113 105 428
trichloromethane 89 90 268 90 96 307
TABLE VI. Table of residence time [ps] of each conformer for the case of an ibuprofen molecule adsorbed on the crystal surface.
adsorbed on an c1 c2 c3 c4 c5 c6
apolar surface [ps] [ps] [ps] [ps] [ps] [ps]
water 95 85 381 91 92 429
1-butanol 166 143 623 148 157 162
cyclohexanone 168 179 675 152 146 1053
cyclohexane 155 148 579 140 183 478
adsorbed on a c1 c2 c3 c4 c5 c6
polar surface [ps] [ps] [ps] [ps] [ps] [ps]
1-butanol 149 197 1316 169 138 123
cyclohexanone 127 180 1187 174 145 5283
acetonitrile 147 168 1998 179 213 603
5TABLE VII. Table of residence time [ps] of each conformer for the case of an ibuprofen molecule in the crystal surface and in
the crystal bulk. The residence time have been recovered from WTmetaD simulations and include the KS statistics p-values
for a 0.95 significance rate.
state in the {100} c1 c2 c3 c4 c5 c6
apolar surface [ps] p-value [ps] p-value [ps] p-value [ps] p-value [ps] p-value [ps] p-value
water 680 0.97 29 0.39 990 0.96 140 0.95 14 0.19 240 0.80
1-butanol 520 0.45 59 0.27 2000 0.68 430 0.96 27 0.98 260 0.28
toluene 600 0.95 48 0.77 1200 0.87 190 0.89 46 0.38 300 0.46
cyclohexanone 890 0.94 31 0.91 1250 0.79 395 0.37 110 0.61 437 0.96
cyclohexane 540 0.84 55 0.37 1840 0.84 270 0.96 38 0.29 320 0.51
acetonitrile 1600 0.97 60 0.91 1570 0.65 267 0.80 16 0.09 330 0.89
trichloromethane 2000 0.59 41 0.90 1400 0.63 400 0.58 11 0.48 420 0.96
state in the {100} c1 c2 c3 c4 c5 c6
polar surface [ps] p-value [ps] p-value [ps] p-value [ps] p-value [ps] p-value [ps] p-value
water 1760 0.91 91 0.97 218 0.20 90 0.72 237 0.80 82 0.14
1-butanol 1300 0.38 131 0.75 1060 0.79 330 0.96 534 0.17 536 0.32
cyclohexanone 1410 0.37 91 0.97 770 0.63 26 0.45 525 0.35 80 0.77
state in the crystal bulk c1
[ps] p-value
92 000 0.98
FIG. S4. Plot of equilibrium probability obtained from WTmetaD and MSM for ibuprofen conformers (orange) and the x = y
function (green).
FIG. S5. Plot of % of conformer c1,found in all different molecule environments and solvent, where (a) concerns the apolar
{100} surface and (b) - the polar.
6FIG. S6. Probability of ibuprofen conformers in solution
FIG. S7. Probability of ibuprofen conformers in adsorbed states
7FIG. S8. Probability of ibuprofen conformers in the surface states
8FIG. S9. Free Energy Surface Summary
9FIG. S10. Convergence Summary
